Lung cancer

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as member Garth explains in this video.

What is lung cancer?

Lung cancers are generally divided into two main categories: small cell lung cancers (SCLC) and non-small cell lung cancers (NSCLC). The type of cancer is determined by looking at the specific type of cancer cells that are present.

Common symptoms reported by people with lung cancer

Common symptoms
How bad it is
What people are taking for it

Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:

Treatments taken by people for lung cancer

Treatment name(s)
Type
How many have tried
Tried for
Treatment name(s)

(Alimta)
Type
Prescription Drug
How many have tried
8
Treatment name(s)

(Taxol)
Type
Prescription Drug
How many have tried
3
Treatment name(s)
Type
Prescription Drug
How many have tried
16
Tried for
lung cancer (3)
Treatment name(s)

(Taxotere)
Type
Prescription Drug
How many have tried
1
Treatment name(s)
Type
Prescription Drug
How many have tried
11
Treatment name(s)

(Toposar)
Type
Prescription Drug
How many have tried
1
Tried for
small cell lung cancer (1)
Treatment name(s)

(Camptosar)
Type
Prescription Drug
How many have tried
0
Treatment name(s)

(Apo-Methotrexate)
Type
Prescription Drug
How many have tried
5
Treatment name(s)

(Navelbine)
Type
Prescription Drug
How many have tried
1

Data from patients with lung cancer, who have ever reported treatments, ordered by their reporting frequency during the last 5 years.
Last updated:

Compare treatments taken by people with lung cancer

Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Treatment name(s)

(Alimta)
Perceived effectiveness
for adenocarcinoma (non-small cell lung cancer) (4 evaluations)
Side effects
cyclic vomiting syndrome itchy rash 4 more
Total evaluations
4
Treatment name(s)

(Taxol)
Perceived effectiveness
for lung cancer (2 evaluations)
Side effects
hair loss rashes (redness, swelling)
Total evaluations
3
Treatment name(s)
Perceived effectiveness
for lung cancer (2 evaluations)
Side effects
Total evaluations
2
Tried for
lung cancer (3)
Treatment name(s)

(Taxotere)
Perceived effectiveness
for non-small cell lung cancer (1 evaluation)
Side effects
nausea
Total evaluations
1
Treatment name(s)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Treatment name(s)

(Toposar)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Tried for
small cell lung cancer (1)
Treatment name(s)

(Camptosar)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Treatment name(s)

(Apo-Methotrexate)
Perceived effectiveness
No evaluations
Side effects
increased anger mental fatigue or exhaustion
Total evaluations
1
Treatment name(s)

(Navelbine)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Data from patients with lung cancer, who have ever reported treatments, ordered by their reporting frequency during the last 5 years.
Last updated:

Who has lung cancer on PatientsLikeMe?

  • 12 new patients joined this month
  • 9174 say lung cancer is their primary condition

Age
Age Proportion # of patients
<20 8
20s 82
30s 201
40s 443
50s 1613
60s 2978
70+ 2472
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 2
20-29 years 17
30-39 years 35
40-49 years 84
50-59 years 191
60-69 years 152
70+ years 54

Distribution of sex

Sex
Sex Proportion # of patients
Male 2373
Female 5640

Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 5877
Not Diagnosed 662

These charts show data from lung cancer patients who have completed their condition history
Last updated: